CLINUVEL PHARMACUTIC-SP ADR

CUVLNASDAQ

Earnings Feb 24US Equity

——

Quote unavailable

Get earnings, price moves & breaking news on Telegram

24h—

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

—

📈Revenue Growth (YoY)

-1.1%

Declining

📊Gross Margin

98.2%

High

💵FCF Margin

37.6%

Strong

⚖️P/S Ratio

3.8x

Fair

Otter Score

—

Insufficient data

Earnings

Q3 · 2026Reported 2026-08-26

Earnings Per Share

Actual

0.34

Expected

0.35

miss

−3.50%

YoY +18.00%

Revenue

Actual

$41.06M

Expected

$42.23M

miss

−2.80%

YoY +5.90%

Consensus estimates

Recent quarters

Q3 2026

0.34

miss

Q1 2026

0.15

miss

Q3 2025

0.29

beat

Q1 2025

0.18

beat